Allelic Expression Imbalance of Human mu Opioid Receptor (OPRM1) Caused by Variant A118G

Mfold web server for nucleic acid folding and hybridization prediction

Zuker, M. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg595 · Cited by 13,404

Endogenous Pain Control Systems: Brainstem Spinal Pathways and Endorphin Circuitry

Basbaum, A. I., & Fields, H. L. (1984) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.07.030184.001521 · Cited by 2,687

Nonsense-mediated mRNA decay: splicing, translation and mRNP dynamics

Maquat, L. E. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1310 · Cited by 1,214

Single-nucleotide polymorphism in the human mu opioid receptor gene alters β-endorphin binding and activity: Possible implications for opiate addiction

Bond, C. E., LaForge, K. S., Tian, M., Melia, D., Zhang, S., Borg, L., Gong, J., Schluger, J. H., Strong, J. A., Leal, S. M., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9608 · Cited by 1,072

Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor

Duan, J. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg055 · Cited by 931

Evolutionary changes in cis and trans gene regulation

Wittkopp, P. J., Haerum, B. K., & Clark, A. G. (2004) · Nature · doi:10.1038/nature02698 · Cited by 873

Endogenous opioid systems and alcohol addiction

Herz, A. (1997) · Psychopharmacology · doi:10.1007/s002130050169 · Cited by 755

A Functional Polymorphism of the μ-Opioid Receptor Gene is Associated with Naltrexone Response in Alcohol-Dependent Patients

Oslin, D. W., Berrettini, W., Kranzler, H. R., Pettinati, H., Gelernter, J., Volpicelli, J. R., & O'Brien, C. P. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300219 · Cited by 571

Allelic Variation in Gene Expression Is Common in the Human GenomePreprint

Lo, H. S., Wang, Z., Hu, Y., Yang, H. H., Gere, S., Buetow, K. H., & Lee, M. P. (2003) · Genome Research · doi:10.1101/gr.1006603 · Cited by 446

A Haplotype Implicated in Schizophrenia Susceptibility Is Associated with Reduced COMT Expression in Human Brain

Bray, N. J., Buckland, P. R., Williams, N. M., Williams, H. J., Norton, N., Owen, M. J., & O’Donovan, M. C. (2003) · The American Journal of Human Genetics · doi:10.1086/376578 · Cited by 335

Critical thoughts on current rodent models for evaluating potential treatments of alcohol addiction and withdrawal

Ripley, T. L., & Stephens, D. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01406.x · Cited by 41

Altered Levels of Basal Cortisol in Healthy Subjects with a 118G Allele in Exon 1 of the Mu Opioid Receptor Gene

Bart, G. B., LaForge, K. S., Borg, L., Lilly, C., Ho, A., & Kreek, M. J. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301128 · Cited by 38

Polymorphism A118G of opioid receptor mu 1 (OPRM1) is associated with emergence of suicidal ideation at antidepressant onset in a large naturalistic cohort of depressed outpatients

Nobile, B., Ramoz, N., Jaussent, I., Gorwood, P. A. P. M., Olié, É., Castroman, J. L., Guillaume, S., & Courtet, P. (2019) · Scientific Reports · doi:10.1038/s41598-019-39622-3 · Cited by 39

Clozapine-Associated Restless Legs Syndrome

Duggal, H. S., & Mendhekar, D. N. (2007) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31802e7587 · Cited by 39

Promoter Polymorphisms in ACE (Angiotensin I–Converting Enzyme) Associated With Clinical Outcomes in Hypertension

Johnson, A., Gong, Y., Wang, D., Langaee, T. Y., Shin, J., Cooper-DeHoff, R., Schork, N. J., Binkley, P. F., Pepine, C. J., Johnson, J. A., et al. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2008.194 · Cited by 38

Functionalmuopioid receptor polymorphism (OPRM1 A118G) associated with heroin use outcomes in Caucasian males: A pilot study

Woodcock, E. A., Lundahl, L. H., Burmeister, M., & Greenwald, M. K. (2015) · American Journal on Addictions · doi:10.1111/ajad.12187 · Cited by 38

The Cholinergic System as a Treatment Target for Opioid Use Disorder

Jensen, K. P., DeVito, E. E., Yip, S. W., Carroll, K. M., & Sofuoglu, M. (2018) · CNS Drugs · doi:10.1007/s40263-018-0572-y · Cited by 37

Escalated Oxycodone Self-Administration and Punishment: Differential Expression of Opioid Receptors and Immediate Early Genes in the Rat Dorsal Striatum and Prefrontal Cortex

Blackwood, C. A., McCoy, M. T., Ladenheim, B., & Cadet, J. L. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01392 · Cited by 39

Mu‐opioid receptor A118G polymorphism in healthy volunteers affects hypothalamic–pituitary–adrenal axis adrenocorticotropic hormone stress response to metyrapone

Ducat, E. A., Ray, B. M., Bart, G. B., Umemura, Y., Varon, J., Ho, A., & Kreek, M. J. (2011) · Addiction Biology · doi:10.1111/j.1369-1600.2011.00313.x · Cited by 37

µ-Opioid Receptor Gene Variant OPRM1 118 A>G: A Summary of its Molecular and Clinical Consequences for Pain

Walter, C., Doehring, A., Oertel, B. G., & Lötsch, J. (2013) · Pharmacogenomics · doi:10.2217/pgs.13.187 · Cited by 36

The Interaction of Reward Genes With Environmental Factors in Contribution to Alcoholism in Mexican Americans

Du, Y., & Wan, Y. Y. (2009) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2009.01050.x · Cited by 36

Polymorphisms in the µ-Opioid Receptor Gene ( OPRM1 ) and the Implications for Alcohol Dependence in Humans

van der Zwaluw, C. S., Wildenberg, E. V. D., Wiers, R. W. H. J., Franke, B., Buitelaar, J. K., Scholte, R. H. J., & Engels, R. C. M. E. (2007) · Pharmacogenomics · doi:10.2217/14622416.8.10.1427 · Cited by 35

Polymorphism of A118G in μ-opioid receptor gene is associated with risk of esophageal squamous cell carcinoma in a Chinese population

Wang, S., Li, Y., Liu, X.-D., Zhao, C., & Kun-qing, Y. (2012) · International Journal of Clinical Oncology · doi:10.1007/s10147-012-0441-5 · Cited by 36

Structural Basis for μ-Opioid Receptor Binding and Activation

Serohijos, A. W. R., Yin, S., Ding, F., Gauthier, J., Gibson, D. G., Maixner, W. D., Dokholyan, N. V., & Diatchenko, L. B. (2011) · Structure · doi:10.1016/j.str.2011.08.003 · Cited by 36

Genetic Variation of the Mu Opioid Receptor (OPRM1) and Dopamine D2 Receptor (DRD2) is Related to Smoking Differences in Patients with Schizophrenia but not Bipolar Disorder

Hirasawa-Fujita, M., Bly, M. J., Ellingrod, V. L., Dalack, G. W., & Domino, E. F. (2017) · Clinical Schizophrenia & Related Psychoses · doi:10.3371/1935-1232-11.1.39 · Cited by 36

Symbiotic relationship of pharmacogenetics and drugs of abuse

Rutter, J. L. (2006) · The AAPS Journal · doi:10.1208/aapsj080121 · Cited by 36

Alcohol: A stimulant activating brain stress responsive systems with persistent neuroadaptation

Zhou, Y., & Kreek, M. J. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.05.044 · Cited by 34

A118G Polymorphism of OPRM1 Gene is Associated with Schizophrenia

Šerý, O., Přikryl, R., Častulík, L., & Šťastný, F. (2010) · Journal of Molecular Neuroscience · doi:10.1007/s12031-010-9327-z · Cited by 33

Candidate gene polymorphisms predicting individual sensitivity to opioids

Kasai, S., Hayashida, M., Sora, I., & Ikeda, K. (2007) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-007-0205-3 · Cited by 33

No evidence of association between 118A>G OPRM1 polymorphism and heroin dependence in a large Bulgarian case–control sample

Nikolov, M. A., Beltcheva, O., Galabova, A., Ljubenova, A., Jankova, E., Gergov, G., Russev, A. A., Lynskey, M. T., Nelson, E. C., Nesheva, E., et al. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.12.026 · Cited by 33

An overview of the genetic susceptibility to alcoholism

Buscemi, L., & Turchi, C. (2011) · Medicine Science and the Law · doi:10.1258/msl.2010.010054 · Cited by 34

Pharmacogenetics and prediction of adverse events in prescription opioid use disorder patients

Muriel, J., Margarit, C., Barrachina, J., Ballester, P., Flor, A., Morales, D., Horga, J. F., Fernández, E., & Peiró, A. M. (2018) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13155 · Cited by 32

μ-Opioid receptor activation prevents acute hepatic inflammation and cell death

Chakass, D. N., Philippe, D., Erdual, E., Dharancy, S., Body–Malapel, M., Dubuquoy, C., Thuru, X., Gay, J., Gavériaux‐Ruff, C., Dubus, P. R., et al. (2007) · Gut · doi:10.1136/gut.2006.105122 · Cited by 32

Allelic imbalance (AI) identifies novel tissue-specificcis-regulatory variation for humanUGT2B15

Sun, C., Southard, C., Witonsky, D., Olopade, O. I., & Rienzo, A. D. (2009) · Human Mutation · doi:10.1002/humu.21145 · Cited by 32

A functional polymorphism of the µ-opioid receptor gene is associated with completed suicides

Hishimoto, A., Cui, H., Mouri, K., Nushida, H., Ueno, Y., Maeda, K., & Shirakawa, O. (2008) · Journal of Neural Transmission · doi:10.1007/s00702-007-0853-y · Cited by 34

Adverse events in analgesic treatment with tramadol associated with CYP2D6 extensive-metaboliser and OPRM1 high-expression variants

Kim, E., Choi, C., Kang, C., & Bae, S. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.124347 · Cited by 32

OPRM1 c.118A>G Polymorphism and Duration of Morphine Treatment Associated with Morphine Doses and Quality-of-Life in Palliative Cancer Pain Settings

Hajj, A., Halepian, L., Osta, N. E., Chahine, G. Y., Kattan, J. G., & Khabbaz, L. R. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18040669 · Cited by 32

Pharmacogenetics of Addiction Therapy

Nielsen, D. A., Nielsen, E. M., Dasari, T., & Spellicy, C. J. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-0956-8_15 · Cited by 32

Lack of association between DRD2 and OPRM1 genotypes and adiposity

Hardman, C. A., Rogers, P. J., Timpson, N. J., & Munafo, M. R. (2013) · International Journal of Obesity · doi:10.1038/ijo.2013.144 · Cited by 31

Genetic variation in the behavioral effects of buprenorphine in female mice derived from a murine model of the OPRM1 A118G polymorphism

Browne, C. A., Erickson, R. L., Blendy, J. A., & Lucki, I. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.02.005 · Cited by 31

Placebo effects and the molecular biological components involved

Cai, L., & He, L. (2019) · General Psychiatry · doi:10.1136/gpsych-2019-100089 · Cited by 33

Influence of the OPRM1 gene polymorphism upon children's degree of withdrawal and brain activation in response to facial expressions

Bertoletti, E., Zanoni, A., Giorda, R., & Battaglia, M. (2011) · Developmental Cognitive Neuroscience · doi:10.1016/j.dcn.2011.05.001 · Cited by 31

A Systematic Review of the A118G (Asn40Asp) Variant ofOPRM1in Relation to Smoking Initiation, Nicotine Dependence and Smoking Cessation

Verhagen, M., Kleinjan, M., & Engels, R. C. M. E. (2012) · Pharmacogenomics · doi:10.2217/pgs.12.76 · Cited by 32

Early parent-child interactions and substance use disorder: An attachment perspective on a biopsychosocial entanglement

Gerra, M. L., Gerra, M. C., Tadonio, L., Pellegrini, P., Marchesi, C., Mattfeld, E., Gerra, G., & Ossola, P. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.09.052 · Cited by 36

Pharmacogenetics of Chronic Pain and Its Treatment

Světlík, S., Hronová, K., Bakhouche, H., Matoušková, O., & Slanař, O. (2013) · Mediators of Inflammation · doi:10.1155/2013/864319 · Cited by 30

The Influence of Genotype Polymorphism on Morphine Analgesic Effect for Postoperative Pain in Children

Lee, M. G., Kim, H. J., Lee, K. H., & Choi, Y. S. (2016) · The Korean journal of pain · doi:10.3344/kjp.2016.29.1.34 · Cited by 30

Association of μ-opioid receptor gene (OPRM1) haplotypes with postoperative nausea and vomiting

Sugino, S., Hayase, T., Higuchi, M., Saito, K., Moriya, H., Kumeta, Y., Kurosawa, N., Namiki, A., & Janicki, P. K. (2014) · Experimental Brain Research · doi:10.1007/s00221-014-3987-9 · Cited by 28

The pharmacogenetics of codeine pain relief in the postpartum period

Baber, M., Chaudhry, S., Kelly, L. E., Ross, C. J., Carleton, B., Berger, H. M., & Koren, G. (2015) · The Pharmacogenomics Journal · doi:10.1038/tpj.2015.3 · Cited by 29

Truncated μ-Opioid Receptors With 6 Transmembrane Domains Are Essential for Opioid Analgesia

Lu, Z., Xu, J., Xu, M., Rossi, G. C., Majumdar, S., Pasternak, G. W., & Pan, Y. (2017) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000002538 · Cited by 29

Pharmacogenetics in Pain Treatment

Peiró, A. M. (2018) · Advances in pharmacology · doi:10.1016/bs.apha.2018.04.004 · Cited by 29

Buprenorphine signalling is compromised at the N 40 D polymorphism of the human μ opioid receptor in vitro

Knapman, A., Santiago, M., & Connor, M. A. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12785 · Cited by 29

Neuroimaging, genetics and the treatment of nicotine addiction

Ray, R., Loughead, J., Wang, Z., Detre, J. A., Yang, E., Gur, R. C., & Lerman, C. E. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.05.021 · Cited by 29

Evidence for population variation in TSC1 and TSC2 gene expression

Jentarra, G. M., Rice, S. G., Olfers, S., Saffen, D. W., & Narayanan, V. (2011) · BMC Medical Genetics · doi:10.1186/1471-2350-12-29 · Cited by 29

Pilot Study Examining the Frequency of Several Gene Polymorphisms Involved in Morphine Pharmacodynamics and Pharmacokinetics in a Morbidly Obese Population

Lloret‐Linares, C., Hajj, A., Poitou, C., Simoneau, G., Clément, K., Laplanche, J., Lépine, J., Bergmann, J., Mouly, S. J., & Peoc’h, K. (2010) · Obesity Surgery · doi:10.1007/s11695-010-0143-x · Cited by 28

A machine-learned knowledge discovery method for associating complex phenotypes with complex genotypes. Application to pain

Lötsch, J., & Ultsch, A. (2013) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2013.07.010 · Cited by 29

µ-Opioid Receptor Gene (OPRM1) Polymorphism A118G: Lack of Association in Finnish Populations with Alcohol Dependence or Alcohol Consumption

Rouvinen-Lagerström, N., Lahti, J. M. T., Alho, H., Kovanen, L., Aalto, M., Partonen, T., Silander, K., Sinclair, D., Räikkönen, K., Eriksson, J. G., et al. (2013) · Alcohol and Alcoholism · doi:10.1093/alcalc/agt050 · Cited by 29

Nicotine-specific and non-specific effects of cigarette smoking on endogenous opioid mechanisms

Nuechterlein, E. B., Ni, L., Domino, E. F., & Zubieta, J. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2016.04.006 · Cited by 28

Dynamic lateral organization of opioid receptors (kappa, muwt and muN40D) in the plasma membrane at the nanoscale level

Rogacki, M. K., Golfetto, O., Tobin, S. J., Li, T., Biswas, S., Jorand, R., Zhang, H., Radoi, V., Yu, M., Svenningsson, P., et al. (2018) · Traffic · doi:10.1111/tra.12582 · Cited by 27

Bidirectional translational research: Progress in understanding addictive diseases

Kreek, M. J., Schlussman, S. D., Reed, B., Zhang, Y., Nielsen, D. A., Levran, O., Zhou, Y., & Butelman, E. R. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.07.042 · Cited by 28

Receptor Reserve Moderates Mesolimbic Responses to Opioids in a Humanized Mouse Model of the OPRM1 A118G Polymorphism

Robinson, J. E., Vardy, E., DiBerto, J. F., Chefer, V. I., White, K. L., Fish, E. W., Chen, M., Gigante, E. D., Krouse, M. C., Sun, H., et al. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.109 · Cited by 28

The human μ-opioid receptor gene polymorphism (A118G) is associated with head pain severity in a clinical cohort of female migraine with aura patients

Menon, S., Lea, R. A., Roy, B., Hanna, M., Wee, S., Haupt, L. M., & Griffiths, L. R. (2012) · The Journal of Headache and Pain · doi:10.1007/s10194-012-0468-z · Cited by 28

An update on the safety of prescribing opioids in pediatrics

Parikh, J. M., Amolenda, P., Rutledge, J., Szabova, A., & Chidambaran, V. (2019) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2019.1571037 · Cited by 30

Functional Polymorphism of the Mu-Opioid Receptor Gene (OPRM1) Influences Reinforcement Learning in Humans

Lee, M. R., Gallen, C. L., Zhang, X., Hodgkinson, C. A., Goldman, D., Stein, E. A., & Barr, C. S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024203 · Cited by 27

A review of the role of genetic testing in pain medicine.

Trescot, A. M., & Faynboym, S. (2014) · PubMed · Cited by 27

Polymorphisms of the μ‐opioid receptor gene influence cerebral pain processing in fibromyalgia

Ellerbrock, I., Sandström, A., Tour, J., Kadetoff, D., Schalling, M., Jensen, K. B., & Kosek, E. (2020) · European Journal of Pain · doi:10.1002/ejp.1680 · Cited by 26

Association study of OPRM1 polymorphisms with Schizophrenia in Han Chinese population

Ding, S., Chen, B., Zheng, Y., Lu, Q., Liu, L., & Zhuge, Q. C. (2013) · BMC Psychiatry · doi:10.1186/1471-244x-13-107 · Cited by 27

Neuroimaging Studies of Primary Dysmenorrhea

Low, I., Wei, S., Lee, P.-S., Li, W., Lee, L.-C., Hsieh, J., & Chen, L. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-1756-9_16 · Cited by 27

Pharmacogenetics of Methadone Response

Fonseca, F., & Torrens, M. (2017) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-017-0311-y · Cited by 26

The OPRM1 A118G polymorphism: converging evidence against associations with alcohol sensitivity and consumption

Sloan, M. E., Klepp, T., Gowin, J. L., Swan, J. E., Sun, H., Stangl, B. L., & Ramchandani, V. A. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-017-0002-8 · Cited by 29

Prefronto-striatal physiology is associated with schizotypy and is modulated by a functional variant of DRD2

Taurisano, P., Romano, R., Mancini, M., Giorgio, A. D., Antonucci, L. A., Fazio, L., Rampino, A., Quarto, T., Gelao, B., Porcelli, A., et al. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00235 · Cited by 27

Sex heterogeneity in pharmacogenetic smoking cessation clinical trials

Schnoll, R. A., & Patterson, F. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2008.11.012 · Cited by 26

Micro Opioid Receptor A118G Polymorphism and Post-Operative Pain: Opioids' Effects on Heterozigous Patients

Capraris, A. D., Cinnella, G., Marolla, A., Salatto, P., Lima, S. D., Vetuschi, P., Consoletti, L., Gesualdo, L., & DAMBROSIO, M. (2011) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463201102400417 · Cited by 26

OPRM1 and ABCB1 Polymorphisms and Their Effect on Postoperative Pain Relief With Piritramide

Bartošová, O., Polanecký, O., Perlík, F., Adámek, S., & Slanař, O. (2015) · Physiological Research · doi:10.33549/physiolres.933210 · Cited by 26

Genetic Influences of OPRM 1, OPRD 1 and COMT on Morphine Analgesia in a Multi‐Modal, Multi‐Tissue Human Experimental Pain Model

Nielsen, L. M., Christrup, L. L., Sato, H., Drewes, A. M., & Olesen, A. E. (2017) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12757 · Cited by 26

Expectancy Modulation of Opioid Neurotransmission

Peciña, M., & Zubieta, J.-K. (2018) · International review of neurobiology · doi:10.1016/bs.irn.2018.02.003 · Cited by 27

Polymorphism in the µ-opioid receptor gene (OPRM1) modulates neural processing of physical pain, social rejection and error processing

Bonenberger, M., Plener, P. L., Groschwitz, R. C., Grön, G., & Abler, B. (2015) · Experimental Brain Research · doi:10.1007/s00221-015-4322-9 · Cited by 28

Genotyping panel for assessing response to cancer chemotherapy

Zunyan Dai, Y., Papp, A. C., Wang, D., Hampel, H., & Sadée, W. (2008) · BMC Medical Genomics · doi:10.1186/1755-8794-1-24 · Cited by 25

Genetics and implications in perioperative analgesia

Trescot, A. M. (2014) · Best practice & research. Clinical anaesthesiology · doi:10.1016/j.bpa.2014.03.004 · Cited by 25

The Value of CYP2D6 and OPRM1 Pharmacogenetic Testing for Opioid Therapy

Reynolds, K. K., Ramey-Hartung, B., & Jortani, S. A. (2008) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2008.10.003 · Cited by 25

RNA Structures Affected By Single Nucleotide Polymorphisms In Transcribed Regions Of The Human Genome

Johnson, A. D. (2011) · Cited by 24

Genetic variability of pain perception and treatment—clinical pharmacological implications

Lötsch, J. (2011) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-011-1012-9 · Cited by 24

Molecular Genetics and New Medication Strategies for Opioid Addiction

Hurd, Y. L., & O’Brien, C. P. (2018) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2018.18030352 · Cited by 27

The Role of Opiates in Social Pain and Suicidal Behavior

Nobile, B., Lutz, P.-E., Olie, E., & Courtet, P. (2020) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2020_167 · Cited by 24

Mu opioid receptor (OPRM1) as a predictor of treatment outcome in opiate-dependent individuals of Arab descent

AL-Eitan, L. N., Jaradat, S. A., Su, S., Tay, G. K., & Hulse (2012) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s33351 · Cited by 27

Trial Protocol: Using genotype to tailor prescribing of nicotine replacement therapy: a randomised controlled trial assessing impact of communication upon adherence

Marteau, T. M., Munafo, M. R., Aveyard, P. N., Hill, C., Whitwell, S., Willis, T. A., Crockett, R. A., Hollands, G. J., Johnstone, E. C., Wright, A. J., et al. (2010) · BMC Public Health · doi:10.1186/1471-2458-10-680 · Cited by 23

Regional brain [ 11 C]carfentanil binding following tobacco smoking

Domino, E. F., Hirasawa-Fujita, M., Ni, L., Guthrie, S. K., & Zubieta, J. K. (2015) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.01.007 · Cited by 23

Influence of theOPRM1A118G Polymorphism on Alcohol-Induced Euphoria, Risk for Alcoholism and the Clinical Efficacy of Naltrexone

Setiawan, E., Pihl, R. O., Benkelfat, C., & Leyton, M. (2012) · Pharmacogenomics · doi:10.2217/pgs.12.99 · Cited by 24

Endogenous opioid system: a promising target for future smoking cessation medications

Norman, H., & D’Souza, M. S. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4582-0 · Cited by 23

Morphine-induced antinociception and reward in “humanized” mice expressing the mu opioid receptor A118G polymorphism

Henderson, A. N., Yuill, M. B., Lowe, T. E., Kline, A. M., Zee, M. L., Guindon, J., & Morgan, D. J. (2015) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2015.10.007 · Cited by 22

μ-Opioid Receptor Gene A118G Polymorphism Predicts Pain Recovery After Sexual Assault

Ballina, L. E., Ulirsch, J. C., Soward, A. C. M., Rossi, C., Rotolo, S., Linnstaedt, S. D., Heafner, T., Foley, K. A., Batts, J. J., Collette, R., et al. (2012) · Journal of Pain · doi:10.1016/j.jpain.2012.10.013 · Cited by 22

In Vitro and Ex Vivo Analysis of CHRNA3 and CHRNA5 Haplotype Expression

Doyle, G. A. R., Wang, M., Chou, A. D., Oleynick, J. U., Arnold, S. E., Buono, R. J., Ferraro, T. N., & Berrettini, W. H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023373 · Cited by 23

Evolving Knowledge of Opioid Genetics in Cancer Pain

Droney, J., Riley, J. L., & Ross, J. R. (2011) · Clinical Oncology · doi:10.1016/j.clon.2011.04.015 · Cited by 22

OPRM1 influence on and effectiveness of an individualized treatment plan for prescription opioid use disorder patients

Muriel, J., Margarit, C., Planelles, B., Serralta, M. J., Puga, C., Inda, M., Cutillas, E., Morales, D., Horga, J. F., & Peiró, A. M. (2018) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13735 · Cited by 22

Positron emission tomography imaging of endogenous mu-opioid mechanisms during pain and migraine

DaSilva, A. F. M., Zubieta, J.-K., & DosSantos, M. F. H. (2019) · PAIN Reports · doi:10.1097/pr9.0000000000000769 · Cited by 24

Cellular signalling of non‐synonymous single‐nucleotide polymorphisms of the human μ‐opioid receptor ( OPRM 1)

Knapman, A., & Connor, M. A. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12644 · Cited by 22

Human Expression Variation in the Mu-Opioid Receptor is Paralleled in Rhesus Macaque

Vallender, E. J., Priddy, C. M., Chen, G., & Miller, G. M. (2008) · Behavior Genetics · doi:10.1007/s10519-008-9207-2 · Cited by 22

The life and times of endogenous opioid peptides: Updated understanding of synthesis, spatiotemporal dynamics, and the clinical impact in alcohol use disorder

Margolis, E. B., Moulton, M. G., Lambeth, P. S., & O’Meara, M. J. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109376 · Cited by 23

Comparison of the Effects of OPRM1 A118G Polymorphism Using Different Opioids: A Prospective Study

Takemura, M., Niki, K., Okamoto, Y., Kawamura, T., Kohno, M., Matsuda, Y., & Ikeda, K. (2023) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2023.09.017 · Cited by 21

A118G Mu Opioid Receptor polymorphism increases inhibitory effects on CaV2.2 channels

Soto, E. J. L., & Raingo, J. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.06.074 · Cited by 21

Testing multiple levels of influence in the intergenerational transmission of alcohol disorders from a developmental perspective: The example of alcohol use promoting peers and μ-opioid receptor M1 variation

Chassin, L., Lee, M. R., Cho, Y. I., Wang, F. L., Arpana Agrawal, A., Sher, K. J., & Lynskey, M. T. (2012) · Development and Psychopathology · doi:10.1017/s0954579412000478 · Cited by 22

The Asp40 μ-Opioid Receptor Allele Does Not Predict Naltrexone Treatment Efficacy in Heavy Drinkers

Mitchell, J., Fields, H. L., White, R. L., Meadoff, T., Joslyn, G., & Rowbotham, M. C. (2007) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31802e68b0 · Cited by 21

Influence of UGT 2B7, CYP 3A4, and OPRM 1 Gene Polymorphisms on Transdermal Buprenorphine Pain Control in Patients with Critical Lower Limb Ischemia Awaiting Revascularization

Antona, F. B., Muriel, C., Labrador, J., González‐Porras, J. R., González‐Sarmiento, R., & Lozano, F. S. (2015) · Pain Practice · doi:10.1111/papr.12343 · Cited by 21

Genetics of fat intake in the determination of body mass

Chmurzyńska, A., & Młodzik-Czyżewska, M. A. (2017) · Nutrition Research Reviews · doi:10.1017/s0954422417000014 · Cited by 21

Recent advances in the use of opioids for cancer pain

Droney, J. (2009) · Journal of Pain Research · doi:10.2147/jpr.s6905 · Cited by 21

Personality traits and polymorphisms of genes coding neurotransmitter receptors or transporters: review of single gene and genome-wide association studies

Zmorzyński, S., Styk, W., Klinkosz, W., Iskra, J., & Filip, A. A. (2021) · Annals of General Psychiatry · doi:10.1186/s12991-021-00328-4 · Cited by 21

Variation in the μ-opioid receptor gene (OPRM1) and experiences of felt security in response to a romantic partner’s quarrelsome behavior

Tchalova, K., Sadikaj, G., Moskowitz, D. S., Zuroff, D. C., & Bartz, J. A. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0600-4 · Cited by 22

Patterns of evolutionary constraints on genes in humans

De, S., López-Bigas, N., & Teichmann, S. A. (2008) · BMC Evolutionary Biology · doi:10.1186/1471-2148-8-275 · Cited by 21

Life‐Threatening Adverse Events Following Therapeutic Opioid Administration in Adults: Is Pharmacogenetic Analysis Useful?

Madadi, P., Sistonen, J., Silverman, G. L., Gladdy, R. A., Ross, C. J., Carleton, B., Carvalho, J. C. A., Hayden, M. R., & Koren, G. (2013) · Pain Research and Management · doi:10.1155/2013/518012 · Cited by 20

The mu-opioid receptor and the evolution of mother–infant attachment: theoretical comment on Higham et al. (2011)

Curley, J. P. (2011) · Behavioral Neuroscience · doi:10.1037/a0022939 · Cited by 19

Allele-Selective Transcriptome Recruitment to Polysomes Primed for Translation: Protein-Coding and Noncoding RNAs, and RNA Isoforms

Mascarenhas, R., Pietrzak, M., Smith, R. M., Webb, A., Wang, D., Papp, A. C., Pinsonneault, J. K., Seweryn, M. T., Rempała, G. A., & Sadée, W. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136798 · Cited by 18

Gene Variant Suggests Link To Addiction Vulnerability

Milne, D. (2005) · Psychiatric News · doi:10.1176/pn.40.21.0028

Consequences of the 118A>G polymorphism in the OPRM1 gene: translation from bench to bedside?

Mura, E., Govoni, S. M., Racchi, M., Carossa, V., Ranzani, G. N., Allegri, M., & van Schaik, R. H. N. (2013) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 7

Single‐nucleotide polymorphism (A118G) in exon 1 ofOPRM1gene causes alteration in downstream signaling by mu‐opioid receptor and may contribute to the genetic risk for addiction

Deb, I., Chakraborty, J., Gangopadhyay, P. K., Choudhury, S. R., & Das, S. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06472.x · Cited by 105

OPRM1 SNP (A118G): Involvement in disease development, treatment response, and animal models

Mague, S. D., & Blendy, J. A. (2010) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.12.016 · Cited by 138

Synaptic Regulation by OPRM1 Variants in Reward Neurocircuitry

Popova, D., Desai, N., Blendy, J. A., & Pang, Z. P. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.2317-18.2019 · Cited by 22